MEDP250516P430000
- 0.00
- 0.000.00%
Medpace Newsroom
Medpace Holdings Insider Sold Shares Worth $516,716, According to a Recent SEC Filing
Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Announces Target Price $300
William Blair Maintains Medpace(MEDP.US) With Hold Rating
Baird Maintains Medpace(MEDP.US) With Hold Rating, Cuts Target Price to $313
Truist Securities Maintains Hold on Medpace Hldgs, Lowers Price Target to $300
Express News | Baird Maintains Neutral on Medpace Hldgs, Lowers Price Target to $313
Deutsche Bank Adjusts Medpace Holdings Price Target to $270 From $280, Maintains Hold Rating
New Analyst Forecast: $MEDP Given 'Market Perform' Rating
Medpace Holdings, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Truist Financial Maintains Medpace(MEDP.US) With Hold Rating
Express News | Medpace Holdings Inc : Mizuho Cuts Target Price to $328 From $355
Q1 2025 Medpace Holdings Inc Earnings Call
Medpace Holdings Reports Strong Q1 2025 Results
Medpace Holdings Inc. Earnings Call: Mixed Sentiments and Modest Growth
Medpace | 10-Q: Q1 2025 Earnings Report
Earnings Call Summary | Medpace(MEDP.US) Q1 2025 Earnings Conference
Medpace Forecasts 2025 Revenue Between $2.14B and $2.24B Amid Funding Challenges
Medpace Drops Despite Q1 Beat Amid Disappointing Performance Metrics
Medpace Downgraded to Market Perform at William Blair Amid Uncertainty
William Blair Downgrades Medpace Hldgs to Market Perform